|
OMIM |
Link |
Information gain |
01 |
|
splenic hypoplasia
|
[NCBI]
|
0.0015596
|
|
|
AVP
|
[NCBI]
|
0.00138333
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.00122671
|
|
|
scott syndrome
|
[NCBI]
|
0.00121267
|
|
|
bleeding disorder, east texas type
|
[NCBI]
|
0.0010375
|
|
|
beta-aminoisobutyric acid, urinary excretion of
|
[NCBI]
|
0.000737684
|
|
|
thrombasthenia-thrombocytopenia, hereditary
|
[NCBI]
|
0.000737684
|
|
|
SLE
|
[NCBI]
|
0.000655195
|
|
|
spondylometaphyseal dysplasia, sedaghatian type
|
[NCBI]
|
0.000644945
|
|
|
cholestasis-lymphedema syndrome
|
[NCBI]
|
0.000613493
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
0.000584941
|
|
|
QPD
|
[NCBI]
|
0.00056504
|
|
|
F3
|
[NCBI]
|
0.000402317
|
|
|
GPS
|
[NCBI]
|
0.000354149
|
|
|
RA
|
[NCBI]
|
0.000269551
|
|
|
bleeding disorder due to p2ry12 defect
|
[NCBI]
|
0.000269041
|
|
|
EPO
|
[NCBI]
|
0.000231432
|
|
|
HFM
|
[NCBI]
|
0.000208625
|
|
|
giant platelet syndrome
|
[NCBI]
|
0.000185969
|
|
|
HPS
|
[NCBI]
|
0.000156511
|
|
|
P2RY12
|
[NCBI]
|
0.000145385
|
|
|
CYP2C9
|
[NCBI]
|
0.000131366
|
|
|
MPO
|
[NCBI]
|
0.000125188
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
0.000124362
|
|
|
LCP2
|
[NCBI]
|
0.000119164
|
|
|
plasmin inhibitor deficiency
|
[NCBI]
|
0.000114912
|
|
|
CF
|
[NCBI]
|
0.000109325
|
|
|
PF4
|
[NCBI]
|
0.000106148
|
|
|
factor xii deficiency
|
[NCBI]
|
0.00010225
|
|
|
platelet factor 3 deficiency
|
[NCBI]
|
0.000101728
|
|
|
lymphoid system deterioration, progressive
|
[NCBI]
|
0.000101728
|
|
|
glaucoma with elevated episcleral venous pressure
|
[NCBI]
|
0.000101728
|
|
|
platelet disorder, undefined
|
[NCBI]
|
0.000101728
|
|
|
HNMT
|
[NCBI]
|
9.85373e-05
|
|
|
GNAQ
|
[NCBI]
|
7.45924e-05
|
|
|
F13A1
|
[NCBI]
|
7.37787e-05
|
|
|
factor x deficiency
|
[NCBI]
|
7.09283e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 2
|
[NCBI]
|
7.08336e-05
|
|
|
GGCX
|
[NCBI]
|
6.75407e-05
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
6.12902e-05
|
|
|
LYZ
|
[NCBI]
|
5.95848e-05
|
|
|
NRP2
|
[NCBI]
|
5.95683e-05
|
|
|
ROCK2
|
[NCBI]
|
5.95683e-05
|
|
|
ZNF385
|
[NCBI]
|
5.95683e-05
|
|
|
FGA
|
[NCBI]
|
5.81661e-05
|
|
|
TFPI
|
[NCBI]
|
5.76735e-05
|
|
|
thrombophilia
|
[NCBI]
|
5.53726e-05
|
|
|
TNF
|
[NCBI]
|
5.46021e-05
|
|
|
FGG
|
[NCBI]
|
5.21358e-05
|
|
|
aspirin resistance
|
[NCBI]
|
5.10781e-05
|
|
|
HHT
|
[NCBI]
|
5.00818e-05
|
|
|
CEACAM5
|
[NCBI]
|
4.97344e-05
|
|
|
FOXF1
|
[NCBI]
|
4.58124e-05
|
|
|
TIE1
|
[NCBI]
|
4.58124e-05
|
|
|
LAMA4
|
[NCBI]
|
4.58124e-05
|
|
|
PTH
|
[NCBI]
|
4.55475e-05
|
|
|
pta deficiency
|
[NCBI]
|
4.49304e-05
|
|
|
F5F8D
|
[NCBI]
|
4.37253e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 1
|
[NCBI]
|
4.37253e-05
|
|
|
chondrodysplasia punctata, autosomal dominant
|
[NCBI]
|
4.15458e-05
|
|
|
von willebrand disease
|
[NCBI]
|
4.13292e-05
|
|
|
multiple coagulation factor deficiency protein 2
|
[NCBI]
|
4.06357e-05
|
|
|
FREM2
|
[NCBI]
|
4.06357e-05
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
4.05625e-05
|
|
|
F2
|
[NCBI]
|
3.76574e-05
|
|
|
PLG
|
[NCBI]
|
3.71294e-05
|
|
|
VKORC1
|
[NCBI]
|
3.47958e-05
|
|
|
SYK
|
[NCBI]
|
3.47958e-05
|
|
|
porphyria, congenital erythropoietic
|
[NCBI]
|
3.37783e-05
|
|
|
NRP1
|
[NCBI]
|
3.2819e-05
|
|
|
LMAN1
|
[NCBI]
|
3.2819e-05
|
|
|
polycythemia vera
|
[NCBI]
|
3.26151e-05
|
|
|
TBXA2R
|
[NCBI]
|
3.11793e-05
|
|
|
GPR30
|
[NCBI]
|
3.11793e-05
|
|
|
ANGPT1
|
[NCBI]
|
3.11793e-05
|
|
|
NGFB
|
[NCBI]
|
3.01736e-05
|
|
|
pheochromocytoma
|
[NCBI]
|
3.00591e-05
|
|
|
THBS1
|
[NCBI]
|
2.97792e-05
|
|
|
PFIC1
|
[NCBI]
|
2.91518e-05
|
|
|
factor v deficiency
|
[NCBI]
|
2.88201e-05
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
2.74953e-05
|
|
|
MEIS1
|
[NCBI]
|
2.74762e-05
|
|
|
FLI1
|
[NCBI]
|
2.65053e-05
|
|
|
HPS1
|
[NCBI]
|
2.56251e-05
|
|
|
FGB
|
[NCBI]
|
2.56251e-05
|
|
|
JAK2
|
[NCBI]
|
2.48541e-05
|
|
|
prekallikrein deficiency
|
[NCBI]
|
2.48206e-05
|
|
|
PLAT
|
[NCBI]
|
2.408e-05
|
|
|
F12
|
[NCBI]
|
2.33942e-05
|
|
|
PCNA
|
[NCBI]
|
2.22944e-05
|
|
|
CFB
|
[NCBI]
|
2.15987e-05
|
|
|
FUS
|
[NCBI]
|
2.15987e-05
|
|
|
VEGF
|
[NCBI]
|
2.15789e-05
|
|
|
CRH
|
[NCBI]
|
1.98939e-05
|
|
|
PTX3
|
[NCBI]
|
1.96512e-05
|
|
|
PRLH
|
[NCBI]
|
1.92241e-05
|
|
|
ALGS1
|
[NCBI]
|
1.88643e-05
|
|
|
WAS
|
[NCBI]
|
1.73605e-05
|
|
|
BTC
|
[NCBI]
|
1.73531e-05
|
|
|
PAI1
|
[NCBI]
|
1.73531e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
1.71645e-05
|
|
|
AFP
|
[NCBI]
|
1.7073e-05
|
|
|
PDGFB
|
[NCBI]
|
1.67048e-05
|
|
|
NPY
|
[NCBI]
|
1.66475e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
1.66183e-05
|
|
|
RDT
|
[NCBI]
|
1.64808e-05
|
|
|
THPO
|
[NCBI]
|
1.61024e-05
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
1.57561e-05
|
|
|
SLC11A2
|
[NCBI]
|
1.47619e-05
|
|
|
CCK
|
[NCBI]
|
1.47331e-05
|
|
|
HEMB
|
[NCBI]
|
1.46021e-05
|
|
|
HMGB1
|
[NCBI]
|
1.4518e-05
|
|
|
GFAP
|
[NCBI]
|
1.44464e-05
|
|
|
F2R
|
[NCBI]
|
1.42812e-05
|
|
|
ITGB3
|
[NCBI]
|
1.42812e-05
|
|
|
NS1
|
[NCBI]
|
1.42299e-05
|
|
|
RUNX1
|
[NCBI]
|
1.40512e-05
|
|
|
NPPA
|
[NCBI]
|
1.33039e-05
|
|
|
MTAP
|
[NCBI]
|
1.29905e-05
|
|
|
WAS
|
[NCBI]
|
1.18821e-05
|
|
|
VHL
|
[NCBI]
|
1.06995e-05
|
|
|
glycogen storage disease i
|
[NCBI]
|
1.06189e-05
|
|
|
KLK3
|
[NCBI]
|
1.05408e-05
|
|
|
ACHE
|
[NCBI]
|
1.05245e-05
|
|
|
TH
|
[NCBI]
|
1.04207e-05
|
|
|
CPB2
|
[NCBI]
|
9.54342e-06
|
|
|
PNMT
|
[NCBI]
|
8.94694e-06
|
|
|
CAT
|
[NCBI]
|
8.19741e-06
|
|
|
ACADM
|
[NCBI]
|
7.24879e-06
|
|
|
HP
|
[NCBI]
|
6.55345e-06
|
|
|
LAM
|
[NCBI]
|
6.43012e-06
|
|
|
COL1A1
|
[NCBI]
|
6.35744e-06
|
|
|
TS
|
[NCBI]
|
6.28745e-06
|
|
|
POMC
|
[NCBI]
|
6.13967e-06
|
|
|
CHS
|
[NCBI]
|
5.68394e-06
|
|
|
TLR4
|
[NCBI]
|
5.09231e-06
|
|
|
MB
|
[NCBI]
|
4.9183e-06
|
|
|
LRP1
|
[NCBI]
|
4.9183e-06
|
|
|
ALB
|
[NCBI]
|
4.55572e-06
|
|
|
TNFSF6
|
[NCBI]
|
4.54083e-06
|
|
|
IFNA1
|
[NCBI]
|
4.53541e-06
|
|
|
TLR2
|
[NCBI]
|
4.43158e-06
|
|
|
PXE
|
[NCBI]
|
4.37918e-06
|
|
|
FMF
|
[NCBI]
|
3.77218e-06
|
|
|
ADM
|
[NCBI]
|
3.19511e-06
|
|
|
hemophilia a
|
[NCBI]
|
3.01064e-06
|
|
|
MUC1
|
[NCBI]
|
2.44582e-06
|
|
|
PYY
|
[NCBI]
|
1.97772e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.62295e-06
|
|
|
STAT3
|
[NCBI]
|
1.43438e-06
|
|
|
FGF7
|
[NCBI]
|
1.39475e-06
|
|
|
phenylketonuria
|
[NCBI]
|
1.37524e-06
|
|
|
CP
|
[NCBI]
|
1.37524e-06
|
|
|
SHBG
|
[NCBI]
|
1.1379e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
1.09354e-06
|
|
|
VIP
|
[NCBI]
|
7.58378e-07
|
|
|
PI
|
[NCBI]
|
7.27391e-07
|
|
|
PRL
|
[NCBI]
|
4.65959e-07
|
|
|
AHR
|
[NCBI]
|
3.42909e-07
|
|
|
TG
|
[NCBI]
|
2.66069e-07
|
|
|
NF1
|
[NCBI]
|
1.94616e-07
|
|
|
temporal arteritis
|
[NCBI]
|
1.32924e-07
|
|
|
PTK2
|
[NCBI]
|
1.19996e-07
|
|
|
XDH
|
[NCBI]
|
2.60188e-09
|
|